China License Out

Announced Date: 2025-02-19 (February 19, 2025) Asset Name: SYS6005 (RB-164) Licensor: CSPC Pharmaceutical Group (China) together … [China BD 2025] CSPC and Radiance enters a 1.24 billion USD license on ROR1 ADC SYS6005 (RB-164)Read more

Announced Date: 2025-01-22 (January 22, 2025) Licensor (Seller): Lepu Biopharma (China) Licensee (Buyer): ArriVent BioPharma (US) … [China BD 2025] Lepu Biopharma and ArriVent enters a 1.2 billion USD License on CDH17 ADC MRG007Read more

Announced Date: 2025-01-13 (January 13, 2025) Asset Name: SIM0500 Licensor: Simcere Zaiming (a subsidiary of Simcere … [China BD 2025] Simcere Zaiming and AbbVie enters a 1 billion license on CFBi GPRC5D/BCMA/CD3 TsAbs SIM0500Read more

Announced Date: 2025-01-10 (January 10, 2025) Asset Name: Undisclosed Licensor: InSilico Medicine (China) Licensee (Buyer): Stemline … [China BD 2025] Insilico Medicine and Menarini (Stemline) enters a 570 million USD license on a  preclinical small molecule assetRead more

Announced Date: 2025-01-10 ( January 10, 2025) Licensor (Seller): Sciwind Biosciences (China) Licensee (Buyer):  Verdiva Bio (US) … [China BD 2025] Sciwind Biosciences and Verdiva Bio enters 2.47 Billion USD License on Three Metabolic Diseases Product CandidatesRead more

Announced Date: 2025-01-07 (January 7, 2025) Asset Name: DB-1418 (AVZO-1418) Licensor (Seller): Duality Biotherapeutics (China) Licensee (Buyer): … [China BD 2025] DualityBio and Avenzo enters a 1.2 billion USD license for EGFR/HER3 BsADC DB-1418 (AVZO-1418)Read more

Announced Date: 2025-01-02 (January 2, 2025) Asset Name: IBI3009 Licensor: Innovent (Innovent Biologics, Inc.，China) Licensee (Buyer): … [China BD 2025] Innovent and Roche enters a 1 billion USD license on DLL3 ADC IBI3009Read more

Announced Date: 2024-12-23 (December 23, 2024) Asset Name: JYB1904 (RPT904) Licensor (Seller): Shanghai Jemincare Pharmaceutical (China) … [China BD 2024] Jemincare and RAPT Therapeutics Enters a 708 million USD License for anti-IgE Monoclonal Antibody JYB1904 (RPT904)Read more

Announced Date: 2024-12-18 (December 18, 2024) Asset Name: HS-10535 Licensor: Hansoh Pharma  (China) Licensee (Buyer):  MSD … [China BD deal 2024]Hansoh and MSD enters a 2 billion USD license on GLP-1Ra HS-10535Read more

Announced Date: 2024-11-18 (November 18, 2024) Asset Name: Licensor: VelaVigo Bio (China) Licensee (Buyer): Avenzo Therapeutics … [China BD 2024] VelaVigo and Avenzo Enters a 800 million USD License on Nectin4/TROP2 BsADC ProgramRead more